专利检索 ap:("Janssen Pharmaceutica, N.V.") AND inv:"GORMLEY, Michael" 第 1 页

1.

发明公开
WHOLE BLOOD BASED MRNA MARKERS FOR PREDICTING PROSTATE CANCER AND METHODS OF DETECTING THE SAME 审中-公开
标题翻译：用于预测前列腺癌的全血基因MRNA标记及其检测方法

公开(公告)号：EP3268493A2

公开(公告)日：2018-01-17

申请号：EP16713202.6

申请日：2016-03-11

申请人： Janssen Pharmaceutica, N.V.

发明人： RICCI, Deborah , GORMLEY, Michael , THOMAS, Shibu , RAJPUROHIT, Yashoda , SCHAFFER, Michael

IPC分类号： C12Q1/68

CPC分类号： C12Q1/6886 , C12Q2600/112 , C12Q2600/158 , C12Q2600/16

摘要： Provided are whole blood based mRNA biomarkers for predicting prostate cancer and methods of detecting the same. The disclosed mRNA markers and methods enable the identification/diagnosis of a patient with prostate cancer, identification of a patient with/prediction of high-risk prostate cancer, and treatment of a patient with prostate cancer. Also provided are gene chips comprising the disclosed whole blood based mRNA biomarkers.

2.

发明公开
BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE 审中-公开
标题翻译：生物标志物鉴定缬氨酸UR UNG UNG UNG UNG AT AT AT AT AT AT AT AT AT AT AT

公开(公告)号：EP3143156A1

公开(公告)日：2017-03-22

申请号：EP15723409.7

申请日：2015-05-07

申请人： Janssen Pharmaceutica, N.V.

发明人： SOKOL RICCI, Deborah , LI, Weimin , GORMLEY, Michael , KARKERA, Jayaprakash , SCHAFFER, Michael

IPC分类号： C12Q1/68

摘要： Provided herein are methods of predicting a likelihood of survival following treatment with AA and prednisone in a patient having CRPC.

摘要翻译： 本文提供了在具有CRPC的患者中用AA和强的松治疗后预测存活可能性的方法。